期刊
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
卷 29, 期 4, 页码 670-674出版社
SAGE PUBLICATIONS INC
DOI: 10.1038/jcbfm.2009.3
关键词
middle cerebral artery occlusion (MCAO); minocycline; poly(ADP-ribose) polymerase (PARP); sex differences
资金
- NIH [R01 NS050505, NS055215]
Minocycline is neuroprotective in clinical and experimental stroke studies, due in part to its ability to inhibit poly (ADP-ribose) polymerase. Previous preclinical data have shown that interference with poly (ADP-ribose) polymerase signaling leads to sex-specific neuroprotection, reducing stroke injury only in males. In this study, we show that minocycline is ineffective at reducing ischemic damage in females after middle cerebral artery occlusion, likely due to effects on poly (ADP-ribose) polymerase signaling. Clinical trials must consider possible sex differences in the response to neuroprotective agents, if we hope to translate promising therapies to stroke patients of both sexes. Journal of Cerebral Blood Flow & Metabolism ( 2009) 29, 670-674; doi:10.1038/jcbfm.2009.3; published online 4 February 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据